We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.31B
AUM Growth
-$8.31M
Cap. Flow
-$167M
Cap. Flow %
-12.7%
Top 10 Hldgs %
42.17%
Holding
161
New
18
Increased
32
Reduced
41
Closed
18

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$11.9M
2
PDD icon
Pinduoduo
PDD
+$10.9M
3
BBIO icon
BridgeBio Pharma
BBIO
+$9.19M
4
ITOS
iTeos Therapeutics
ITOS
+$6.95M
5
NE icon
Noble Corp
NE
+$6.73M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$36.5M
2
BWA icon
BorgWarner
BWA
+$13.2M
3
SE icon
Sea Limited
SE
+$12.1M
4
BABA icon
Alibaba
BABA
+$9.88M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$7.45M

Sector Composition

Rank Sector Weight
1 Healthcare 23.33%
2 Consumer Discretionary 14.69%
3 Financials 6.56%
4 Materials 4.95%
5 Communication Services 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
PUT
Eli Lilly
LLY
$1.07T
$177M 13.48%
200,000
+9,000
+5% +$8.09M
TSLA icon
2
PUT
Tesla
TSLA
$1.24T
$65.4M 4.97%
250,000
-113,000
-31% -$25.8M
COF icon
3
Capital One
COF
$124B
$50.2M 3.81%
335,000
– –
ERO icon
4
Ero Copper
ERO
$2.71B
$45.6M 3.47%
2,050,000
+50,000
+3% +$1.02M
HGV icon
5
Hilton Grand Vacations
HGV
$3.84B
$44.5M 3.38%
1,225,000
-75,675
-6% -$2.93M
CVNA icon
6
Carvana
CVNA
$43.3B
$39.2M 2.98%
1,125,000
-250,000
-18% -$7.18M
WVE icon
7
Wave Life Sciences
WVE
$1.12B
$34.4M 2.62%
4,200,000
-1,125,000
-21% -$6.72M
ALNY icon
8
PUT
Alnylam Pharmaceuticals
ALNY
$36.3B
$33.9M 2.58%
123,300
+400
+0.3% +$104K
CCOI icon
9
Cogent Communications
CCOI
$594M
$28.8M 2.19%
380,000
+5,000
+1% +$344K
TGTX icon
10
TG Therapeutics
TGTX
$8.58B
$26.5M 2.02%
1,135,000
-265,000
-19% -$5.79M
BWA icon
11
BorgWarner
BWA
$13.2B
$25.4M 1.93%
700,000
-400,000
-36% -$13.2M
OXY.WS icon
12
Occidental Petroleum Corp Warrants
OXY.WS
$33.2B
$25.4M 1.93%
854,600
– –
VKTX icon
13
Viking Therapeutics
VKTX
$4.04B
$20.3M 1.54%
320,000
-20,000
-6% -$1.17M
MREO
14
Mereo BioPharma
MREO
$45.9M
$19.9M 1.52%
4,849,800
-150,200
-3% -$621K
LEN.B icon
15
Lennar Class B
LEN.B
$20B
$19.9M 1.51%
120,980
– –
SN icon
16
SharkNinja
SN
$21B
$19.6M 1.49%
180,000
-420,000
-70% -$36.5M
XHR
17
Xenia Hotels & Resorts
XHR
$1.98B
$19.5M 1.48%
1,320,000
-5,000
-0.4% -$69.4K
PM icon
18
Philip Morris
PM
$301B
$19.4M 1.48%
160,000
+10,000
+7% +$1.16M
PTGX icon
19
Protagonist Therapeutics
PTGX
$8.75B
$18.9M 1.44%
420,000
-184,449
-31% -$7.45M
PHAT icon
20
Phathom Pharmaceuticals
PHAT
$912M
$18.3M 1.39%
1,010,000
-390,000
-28% -$5.45M
GXO icon
21
GXO Logistics
GXO
$6.06B
$18.2M 1.39%
350,000
+100,000
+40% +$5.07M
BIDU icon
22
Baidu
BIDU
$35.8B
$17.4M 1.32%
165,000
+135,000
+450% +$11.9M
INSE icon
23
Inspired Entertainment
INSE
$177M
$16.5M 1.26%
1,785,000
– –
ITOS
24
DELISTED
iTeos Therapeutics
ITOS
$16M 1.22%
1,570,288
+455,288
+41% +$6.95M
COF icon
25
PUT
Capital One
COF
$124B
$15M 1.14%
100,000
– –
1
2 3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, 683 Capital Management held 161 positions worth $1.31B, down 0.63% from $1.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

683 Capital Management withdrew a net $167M in Q3 2024, closing 18 positions and reducing 41 holdings. Its most notable exit was Sea Limited, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Pinduoduo worth $12M.

  • 683 Capital Management's largest Q3 2024 buy was Pinduoduo: 89,000 shares worth $12M.
  • 683 Capital Management added most to Baidu in Q3 2024, an estimated $11.9M increase.
  • 683 Capital Management's biggest Q3 2024 reduction was SharkNinja, cutting an estimated $36.5M.
  • 683 Capital Management fully exited Sea Limited in Q3 2024, selling an estimated $12.1M.
  • 683 Capital Management's ten largest holdings make up 42% of its $1.31B portfolio in Q3 2024.
  • 683 Capital Management opened 18 new positions and closed 18 in Q3 2024.
  • 683 Capital Management's portfolio value fell 0.63% quarter-over-quarter to $1.31B.

Based on 683 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.